Bristlecone Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,250
| Closed | -$1.09M | – | 377 |
|
|
2025
Q1 | $1.09M | Buy |
2,250
+100
| +5% | +$48.5K | 0.09% | 146 |
|
|
2024
Q4 | $866K | Hold |
2,150
| – | – | 0.07% | 157 |
|
|
2024
Q3 | $1,000K | Hold |
2,150
| – | – | 0.08% | 140 |
|
|
2024
Q2 | $1.01M | Sell |
2,150
-15
| -0.7% | -$7.03K | 0.09% | 140 |
|
|
2024
Q1 | $905K | Buy |
2,165
+115
| +6% | +$48.1K | 0.08% | 146 |
|
|
2023
Q4 | $834K | Buy |
2,050
+5
| +0.2% | +$2.03K | 0.08% | 148 |
|
|
2023
Q3 | $711K | Sell |
2,045
-56
| -3% | -$19.5K | 0.08% | 146 |
|
|
2023
Q2 | $739K | Sell |
2,101
-58
| -3% | -$20.4K | 0.07% | 149 |
|
|
2023
Q1 | $680K | Sell |
2,159
-326
| -13% | -$103K | 0.07% | 149 |
|
|
2022
Q4 | $718K | Sell |
2,485
-51
| -2% | -$14.7K | 0.09% | 145 |
|
|
2022
Q3 | $734K | Sell |
2,536
-29
| -1% | -$8.39K | 0.1% | 137 |
|
|
2022
Q2 | $723K | Buy |
2,565
+302
| +13% | +$85.1K | 0.09% | 138 |
|
|
2022
Q1 | $591K | Buy |
2,263
+24
| +1% | +$6.27K | 0.07% | 148 |
|
|
2021
Q4 | $492K | Buy |
2,239
+274
| +14% | +$60.2K | 0.06% | 167 |
|
|
2021
Q3 | $356K | Buy |
1,965
+410
| +26% | +$74.3K | 0.05% | 171 |
|
|
2021
Q2 | $314K | Buy |
1,555
+21
| +1% | +$4.24K | 0.04% | 178 |
|
|
2021
Q1 | $330K | Buy |
1,534
+171
| +13% | +$36.8K | 0.05% | 171 |
|
|
2020
Q4 | $322K | Buy |
+1,363
| New | +$322K | 0.05% | 169 |
|